Literature DB >> 21466569

Consumption of three most widely used analgesics in six European countries.

R Hudec1, L Božeková, J Tisoňová.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Analgesics are among the most widely used drugs and there is wide intercountry variability in the rates of consumption of different analgesics. Our objective is to determine and compare patterns of analgesic consumption in the Slovak Republic and a number of other European countries.
METHODS: We undertook a drug utilization study using WHO ATC/defined daily doses (DDD) methodology. Wholesale analgesic data collected by the Slovak State Institute for Drug Control were used. Utilization was calculated as DDD per 1000 inhabitants per day. Comparison with wholesale data from Czech Republic, Estonia, Finland, Norway and Denmark, published on the Internet, was made. RESULTS AND DISCUSSION: Paracetamol/acetaminophen consumption varied only a little in Slovak Republic and Czech Republic, whereas consumption in Nordic countries was significantly higher (P < 0.05) and in Estonia significantly lower. Ibuprofen consumption was significantly higher in Czech Republic and Finland. Significantly lower consumption was in Norway. The lowest consumption of ASA/aspirin was in Denmark and in Norway. The highest consumption was in Finland. WHAT IS NEW AND
CONCLUSION: Effective therapy needs good prescribing and well-informed prescribers and patients. Our study highlights wide differences in analgesic consumption even among similar European countries. The basis of these differences and their potential clinical impact require further investigation.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21466569     DOI: 10.1111/j.1365-2710.2011.01256.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  8 in total

1.  Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe.

Authors:  Karima Hider-Mlynarz; Philippe Cavalié; Patrick Maison
Journal:  Br J Clin Pharmacol       Date:  2018-04-02       Impact factor: 4.335

2.  COX-2 inhibitor and non-selective NSAID use in those at increased risk of NSAID-related adverse events: a retrospective database study.

Authors:  Svetla Gadzhanova; Jenni Ilomäki; Elizabeth E Roughead
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

Review 3.  Organic micropollutants paracetamol and ibuprofen-toxicity, biodegradation, and genetic background of their utilization by bacteria.

Authors:  Joanna Żur; Artur Piński; Ariel Marchlewicz; Katarzyna Hupert-Kocurek; Danuta Wojcieszyńska; Urszula Guzik
Journal:  Environ Sci Pollut Res Int       Date:  2018-06-19       Impact factor: 4.223

4.  Factors Influencing Pain Management of Patients with Osteoarthritis: A Cross-Sectional Study.

Authors:  Gyöngyi Anna Mezey; Zsuzsanna Máté; Edit Paulik
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

Review 5.  COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview.

Authors:  Sergio Pandolfi; Luigi Valdenassi; Geir Bjørklund; Salvatore Chirumbolo; Roman Lysiuk; Larysa Lenchyk; Monica Daniela Doşa; Serafino Fazio
Journal:  Int J Environ Res Public Health       Date:  2022-04-02       Impact factor: 3.390

6.  Paracetamol and Ibuprofen Removal from Aqueous Phase Using a Ceramic-Derived Activated Carbon.

Authors:  Amalia L Bursztyn Fuentes; Damián E Benito; María L Montes; Alberto N Scian; M Barbara Lombardi
Journal:  Arab J Sci Eng       Date:  2022-10-03       Impact factor: 2.807

7.  Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study.

Authors:  Skaistė Kasciuškevičiūtė; Gintautas Gumbrevičius; Aušra Vendzelytė; Arūnas Ščiupokas; Kęstutis Petrikonis; Edmundas Kaduševičius
Journal:  Medicina (Kaunas)       Date:  2018-05-11       Impact factor: 2.430

8.  Acetaminophen (Paracetamol) Exposure During Pregnancy and Pubertal Development in Boys and Girls From a Nationwide Puberty Cohort.

Authors:  Andreas Ernst; Nis Brix; Lea L B Lauridsen; Jørn Olsen; Erik T Parner; Zeyan Liew; Lars H Olsen; Cecilia H Ramlau-Hansen
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.